Autor:	Prigitano, A., Esposto, M.C., Grancini, A., Passera, M., Paolucci, M., Stanzani, M., Sartor, A., Candoni, A., Pitzurra, L., Innocenti, P., Micozzi, A., Cascio, G. Lo, Delia, M., Mosca, A., Mikulska, M., Ossi, C., Fontana, C., Pizzolante, M., Gelmi, M., Cavanna, C., Lallitto, F., Amato, G., Vella, A., Pagano, L., Bandettini, R., De Lorenzis, G., Cogliati, M., Romanò, L., Tortorano, A.
Zdroj:	Journal of Global Antimicrobial Resistance; September 2020, Vol. 22 Issue: 1 p231-237, 7p
Abstrakt:	•The prevalence of azole resistance was 1.3% in haematological patients.•The itraconazole resistance rate was 1.48% considering Aspergillus,section Fumigati.•Two cryptic azole-resistant species were identified, Aspergillus lentulusand Aspergillus awamori.
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect